Elocalcitol reverses energy overconsumption driven cellular senescence.

Adge Pharmaceuticals prepares to evaluate elocalcitol for the treatment of obesity and metabolic syndrome.

Adge Pharmaceuticals partners with Cyan Bio of Korea to advance treatments for rare pediatric diseases in Asian countries.

Adge Pharmaceuticals advances its rare disease programs, attends ASCEND 2022 Rett Syndrome National Summit.

Adge Pharmaceuticals secures license to evaluate two new programs in rare pediatric diseases.